or Try an Advanced Search...

    Technical Analysis for VALN - Valneva SE

    Grade Last Price % Change Price Change
    F 9.07 1.90% 0.17
    VALN closed up 1.9 percent on Friday, May 31, 2024, on 44 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical VALN trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Pocket Pivot Bullish Swing Setup 1.90%
    Wide Bands Range Expansion 1.90%
    Gapped Up Strength 1.90%
    Overbought Stochastic Strength 1.90%
    Up 3 Days in a Row Strength 1.90%
    180 Bullish Setup Bullish Swing Setup 2.01%
    Older End-of-Day Signals for VALN ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 2 days ago
    60 Minute Opening Range Breakout 2 days ago
    Rose Above Previous Day's High 2 days ago
    Up 1% 2 days ago
    60 Minute Opening Range Breakdown 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VALN Chart by TradingView
    Basic chart:

    Profile

    Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Infectious Diseases Vaccines Medical Research Vaccination Virology Lyme Disease

    Is VALN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 31 Valneva nabs EU backing for Chikungunya vaccine
    May 31 Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
    May 21 Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
    May 13 Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine
    May 8 Cracking The Code: Understanding Analyst Reviews For Valneva
    May 7 Valneva reports Q1 results
    May 7 Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 6 Declaration of shares and voting rights April 30, 2024 - VALNEVA SE
    Apr 4 Declaration of voting rights - Valneva SE, March 2024
    Mar 26 Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
    See more VALN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.05
    52 Week Low 6.5901
    Average Volume 11,049
    200-Day Moving Average 10.01
    50-Day Moving Average 8.06
    20-Day Moving Average 8.25
    10-Day Moving Average 8.73
    Average True Range 0.38
    RSI (14) 63.10
    ADX 20.78
    +DI 32.56
    -DI 19.35
    Chandelier Exit (Long, 3 ATRs) 7.94
    Chandelier Exit (Short, 3 ATRs) 8.19
    Upper Bollinger Bands 9.55
    Lower Bollinger Band 6.96
    Percent B (%b) 0.81
    BandWidth 31.40
    MACD Line 0.30
    MACD Signal Line 0.22
    MACD Histogram 0.0731
    Fundamentals Value
    Market Cap 629.33 Million
    Num Shares 69.4 Million
    EPS -1.77
    Price-to-Earnings (P/E) Ratio -5.12
    Price-to-Sales 2.51
    Price-to-Book 3.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.38
    Resistance 3 (R3) 9.35 9.22 9.33
    Resistance 2 (R2) 9.22 9.14 9.24 9.31
    Resistance 1 (R1) 9.15 9.09 9.18 9.17 9.30
    Pivot Point 9.01 9.01 9.03 9.03 9.01
    Support 1 (S1) 8.94 8.93 8.97 8.96 8.84
    Support 2 (S2) 8.80 8.88 8.82 8.83
    Support 3 (S3) 8.73 8.80 8.81
    Support 4 (S4) 8.76